VL
ABBV icon

Vima LLC’s AbbVie ABBV Stock Holding History

Vima LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.1K Buy
+80
New +$17.2K 0.02% 221

Other funds holding ABBV

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Vima LLC's ABBV Position: Q2 2026 in Review

Vima LLC opened a new position in AbbVie (ABBV) in Q2 2026: 80 shares worth $20.1K. The stake represents 0.02% of the portfolio and ranks #221 among its holdings.

2,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vima LLC held 80 shares of AbbVie worth $20.1K as of Q2 2026.
  • AbbVie was a new Vima LLC position in Q2 2026.
  • AbbVie made up 0.02% of Vima LLC's portfolio in Q2 2026, its #221 holding.
  • 2,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vima LLC's 13F filing for Q2 2026, filed 24 Jul 2026.